Impact of the Look AHEAD Intervention on NT-pro Brain Natriuretic Peptide in Overweight and Obese Adults With Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of the Look AHEAD Intervention on NT-pro Brain Natriuretic Peptide in Overweight and Obese Adults With Diabetes

Published:2012-07 Issue:7 Volume:20 Page:1511-1518
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:

Author:

Bertoni Alain G.,Wagenknecht Lynne E.,Kitzman Dalane W.,Marcovina Santica M.,Rushing Julia T.,Espeland Mark A.,

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/oby.2011.296/fullpdf

Reference42 articles.

1. The incidence of congestive heart failure in type 2 diabetes: an update;Nichols;Diabetes Care,2004

2. Heart failure prevalence, incidence, and mortality in the elderly with diabetes;Bertoni;Diabetes Care,2004

3. Heart Failure: the frequent, forgotten, and often fatal complication of diabetes;Bell;Diabetes Care,2003

4. Biomarkers in heart failure;Braunwald;N Engl J Med,2008

5. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations;Groenning;Am Heart J,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semaglutide and NT-proBNP in Obesity-Related HFpEF;Journal of the American College of Cardiology;2024-07

2. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials;The Lancet;2024-04

3. Safe de-escalation of chemotherapy in HER2-positive early breast cancer;The Lancet;2024-04

4. Semaglutide—a new treatment for obesity-related heart failure with preserved ejection fraction?;The Lancet;2024-04

5. Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial;Circulation;2024-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3